Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Pre-operative Intravenous Tranexamic Acid Versus Rectal Misoprostol in Reducing Blood Loss During and After Elective Cesarean Section in Primigravida: A Double-blinded, Randomized, Controlled Trial

NCT04635007 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04635007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Pre-operative Intravenous Tranexamic Acid Versus Rectal Misoprostol in Reducing Blood Loss During and After Elective Cesarean Section in Primigravida: A Double-blinded, Randomized, Controlled Trial
Lead sponsor
Cairo University
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2021
Completion date
June 30, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, surgical, cesarean section complications, misoprostol, tranexamic acid